Trial Profile
A study to compare the effects of bosentan on endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 27 Oct 2015 New trial record
- 29 Aug 2015 Results published at ESC Congress 2015: Annual Congress of the European Society of Cardiology